Investigation into CREB induced growth and apoptosis of ovine ovarian surface epithelial cells;

Clinical analysis of paclitaxel liposome combined with carboplatin in the treatment of advanced epithelial ovarian cancer;

Clinical significance of DNA content and cell cycle phase analysis in epithelial ovarian cancer;

Effect of individual treatment of recarrent epithelial ovarian cancer with ascites

The application value of combined detection of serum levels of OPN and CA_(125) in the diagnosis and treatment of ovarian epithelial cancer;

The detection of serum CA125 in patients with ovarian epithelial cancer by chemical luminal immunoassay;

Prognostic factors of epithelial ovarian carcinoma in patients with age under 40;

Objective To evaluate the effects of plasma lysophosphatidic acid(LPA)on the carcinogenesis of epithelial ovarian carcinoma and the diagnosis.

Thirty-four epithelial ovarian carcinoma (EOC) patients with ascites were divided into two groups: group A (n=22) receiving preoperative chemotherapy with PAC regimen plus abdominal cavity chemotherapy 2 or 3 cycles; group B (n=12) undergoing abdominal chemotherapy only 2 cycels.

Objective To explore the value of serum CA125,CA199 on diagnosis and prognosis in ovarian cancer.

Methods:Protein of nm23 gene was detected by immunohistochemical technique in 45 patients with epithelial ovarian cancer, 12 with borderline, and 10 with benign ovarian tumor.

Objective:To clone plasminogen activator (uPA) and plasminogen activator inhibitor-1(PAI-1) gene from ovarian cancer tissue and construct the eukaryotic expressive vector for uPA and PAI-1 gene.

Role of high mobility group A1 small interference RNA in a ovarian carcinoma cell line;